aluates Reports

$ 0.0

Global Genetic Toxicology Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-28R11725

Global Genetic Toxicology Market Research Report 2022

BUY CHAPTERS

Global Genetic Toxicology Market Research Report 2025

Code: QYRE-Auto-28R11725

Report

February 2025

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Accelera

Charles River

Syngene

Vivotecnia

Technics

ERBC Group

Nextgen

Cardinal Health

Toxys

Abbott Toxicology

Evotec AG

EPL Limited

Frontage Laboratories

Pharmaron

LabCorp

Aurigene Pharmaceutical Services

Genetic Toxicology Market Size

The global market for Genetic Toxicology was valued at US$ 235070 million in the year 2024 and is projected to reach a revised size of US$ 344650 million by 2031, growing at a CAGR of 5.7% during the forecast period.

Genetic Toxicology Market

Genetic toxicology is a branch of toxicology that focuses on the study of the genetic damage or mutations caused by various physical, chemical, and biological agents. These agents, often referred to as genotoxic agents, have the potential to alter the genetic material within cells, including DNA, which can lead to mutations or other genetic changes. Genetic toxicology is an important field for assessing the safety of various substances, including pharmaceuticals, chemicals, environmental pollutants, and radiation.

Increased Regulatory Scrutiny: Regulatory agencies worldwide continue to emphasize the importance of genetic toxicology testing in assessing the safety of pharmaceuticals, chemicals, and various products. The demand for such testing is likely to remain high as regulations evolve.

Advancements in Testing Methods: The field of genetic toxicology has seen advances in testing methods and technologies. This includes the development of more sensitive and specific assays, high-throughput screening, and the use of 3D cell culture models, which enhance the accuracy and efficiency of testing.

Growing Demand for In Vitro Testing: There"s a shift toward in vitro (test tube or cell-based) genetic toxicology testing, which can reduce the need for animal testing and offer faster and more cost-effective results. This is in line with broader trends in reducing animal testing.

Assessment of Genomic Data: With the increasing availability of genomic data, there"s a trend toward integrating genomics and bioinformatics into genetic toxicology studies. This allows for a deeper understanding of mechanisms and the identification of genetic biomarkers for toxicity.

This report aims to provide a comprehensive presentation of the global market for Genetic Toxicology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Toxicology.

The Genetic Toxicology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genetic Toxicology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Genetic Toxicology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Genetic Toxicology Market Report

Report Metric	Details
Report Name	Genetic Toxicology Market
Accounted market size in year	US$ 235070 million
Forecasted market size in 2031	US$ 344650 million
CAGR	5.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Genotoxicity Screening Assays GLP Standard Genotoxicity Assays
Segment by Application	Mini Ames/Ames Gene Mutation In Vitro Micronucleus Chromosome Aberration Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Frontage Laboratories, Accelera, Charles River, Pharmaron, Labcorp, Syngene, Vivotecnia, Technics, Aurigene Pharmaceutical Services, ERBC Group, NextGen, Cardinal Health, Toxys, Abbott Toxicology, Evotec, EPL
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genetic Toxicology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Genetic Toxicology Market growing?

Ans: The Genetic Toxicology Market witnessing a CAGR of 5.7% during the forecast period 2025-2031.

What is the Genetic Toxicology Market size in 2031?

Ans: The Genetic Toxicology Market size in 2031 will be US$ 344650 million.

Who are the main players in the Genetic Toxicology Market report?

Ans: The main players in the Genetic Toxicology Market are Frontage Laboratories, Accelera, Charles River, Pharmaron, Labcorp, Syngene, Vivotecnia, Technics, Aurigene Pharmaceutical Services, ERBC Group, NextGen, Cardinal Health, Toxys, Abbott Toxicology, Evotec, EPL

What are the Application segmentation covered in the Genetic Toxicology Market report?

Ans: The Applications covered in the Genetic Toxicology Market report are Mini Ames/Ames, Gene Mutation, In Vitro Micronucleus, Chromosome Aberration, Others

What are the Type segmentation covered in the Genetic Toxicology Market report?

Ans: The Types covered in the Genetic Toxicology Market report are Genotoxicity Screening Assays, GLP Standard Genotoxicity Assays

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Genetic Toxicology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Genotoxicity Screening Assays

1.2.3 GLP Standard Genotoxicity Assays

1.3 Market by Application

1.3.1 Global Genetic Toxicology Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Mini Ames/Ames

1.3.3 Gene Mutation

1.3.4 In Vitro Micronucleus

1.3.5 Chromosome Aberration

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Genetic Toxicology Market Perspective (2020-2031)

2.2 Global Genetic Toxicology Growth Trends by Region

2.2.1 Global Genetic Toxicology Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Genetic Toxicology Historic Market Size by Region (2020-2025)

2.2.3 Genetic Toxicology Forecasted Market Size by Region (2026-2031)

2.3 Genetic Toxicology Market Dynamics

2.3.1 Genetic Toxicology Industry Trends

2.3.2 Genetic Toxicology Market Drivers

2.3.3 Genetic Toxicology Market Challenges

2.3.4 Genetic Toxicology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Genetic Toxicology Players by Revenue

3.1.1 Global Top Genetic Toxicology Players by Revenue (2020-2025)

3.1.2 Global Genetic Toxicology Revenue Market Share by Players (2020-2025)

3.2 Global Genetic Toxicology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Genetic Toxicology Revenue

3.4 Global Genetic Toxicology Market Concentration Ratio

3.4.1 Global Genetic Toxicology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Genetic Toxicology Revenue in 2024

3.5 Global Key Players of Genetic Toxicology Head office and Area Served

3.6 Global Key Players of Genetic Toxicology, Product and Application

3.7 Global Key Players of Genetic Toxicology, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Genetic Toxicology Breakdown Data by Type

4.1 Global Genetic Toxicology Historic Market Size by Type (2020-2025)

4.2 Global Genetic Toxicology Forecasted Market Size by Type (2026-2031)

5 Genetic Toxicology Breakdown Data by Application

5.1 Global Genetic Toxicology Historic Market Size by Application (2020-2025)

5.2 Global Genetic Toxicology Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Genetic Toxicology Market Size (2020-2031)

6.2 North America Genetic Toxicology Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Genetic Toxicology Market Size by Country (2020-2025)

6.4 North America Genetic Toxicology Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Genetic Toxicology Market Size (2020-2031)

7.2 Europe Genetic Toxicology Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Genetic Toxicology Market Size by Country (2020-2025)

7.4 Europe Genetic Toxicology Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Genetic Toxicology Market Size (2020-2031)

8.2 Asia-Pacific Genetic Toxicology Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Genetic Toxicology Market Size by Region (2020-2025)

8.4 Asia-Pacific Genetic Toxicology Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Genetic Toxicology Market Size (2020-2031)

9.2 Latin America Genetic Toxicology Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Genetic Toxicology Market Size by Country (2020-2025)

9.4 Latin America Genetic Toxicology Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Genetic Toxicology Market Size (2020-2031)

10.2 Middle East & Africa Genetic Toxicology Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Genetic Toxicology Market Size by Country (2020-2025)

10.4 Middle East & Africa Genetic Toxicology Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Frontage Laboratories

11.1.1 Frontage Laboratories Company Details

11.1.2 Frontage Laboratories Business Overview

11.1.3 Frontage Laboratories Genetic Toxicology Introduction

11.1.4 Frontage Laboratories Revenue in Genetic Toxicology Business (2020-2025)

11.1.5 Frontage Laboratories Recent Development

11.2 Accelera

11.2.1 Accelera Company Details

11.2.2 Accelera Business Overview

11.2.3 Accelera Genetic Toxicology Introduction

11.2.4 Accelera Revenue in Genetic Toxicology Business (2020-2025)

11.2.5 Accelera Recent Development

11.3 Charles River

11.3.1 Charles River Company Details

11.3.2 Charles River Business Overview

11.3.3 Charles River Genetic Toxicology Introduction

11.3.4 Charles River Revenue in Genetic Toxicology Business (2020-2025)

11.3.5 Charles River Recent Development

11.4 Pharmaron

11.4.1 Pharmaron Company Details

11.4.2 Pharmaron Business Overview

11.4.3 Pharmaron Genetic Toxicology Introduction

11.4.4 Pharmaron Revenue in Genetic Toxicology Business (2020-2025)

11.4.5 Pharmaron Recent Development

11.5 Labcorp

11.5.1 Labcorp Company Details

11.5.2 Labcorp Business Overview

11.5.3 Labcorp Genetic Toxicology Introduction

11.5.4 Labcorp Revenue in Genetic Toxicology Business (2020-2025)

11.5.5 Labcorp Recent Development

11.6 Syngene

11.6.1 Syngene Company Details

11.6.2 Syngene Business Overview

11.6.3 Syngene Genetic Toxicology Introduction

11.6.4 Syngene Revenue in Genetic Toxicology Business (2020-2025)

11.6.5 Syngene Recent Development

11.7 Vivotecnia

11.7.1 Vivotecnia Company Details

11.7.2 Vivotecnia Business Overview

11.7.3 Vivotecnia Genetic Toxicology Introduction

11.7.4 Vivotecnia Revenue in Genetic Toxicology Business (2020-2025)

11.7.5 Vivotecnia Recent Development

11.8 Technics

11.8.1 Technics Company Details

11.8.2 Technics Business Overview

11.8.3 Technics Genetic Toxicology Introduction

11.8.4 Technics Revenue in Genetic Toxicology Business (2020-2025)

11.8.5 Technics Recent Development

11.9 Aurigene Pharmaceutical Services

11.9.1 Aurigene Pharmaceutical Services Company Details

11.9.2 Aurigene Pharmaceutical Services Business Overview

11.9.3 Aurigene Pharmaceutical Services Genetic Toxicology Introduction

11.9.4 Aurigene Pharmaceutical Services Revenue in Genetic Toxicology Business (2020-2025)

11.9.5 Aurigene Pharmaceutical Services Recent Development

11.10 ERBC Group

11.10.1 ERBC Group Company Details

11.10.2 ERBC Group Business Overview

11.10.3 ERBC Group Genetic Toxicology Introduction

11.10.4 ERBC Group Revenue in Genetic Toxicology Business (2020-2025)

11.10.5 ERBC Group Recent Development

11.11 NextGen

11.11.1 NextGen Company Details

11.11.2 NextGen Business Overview

11.11.3 NextGen Genetic Toxicology Introduction

11.11.4 NextGen Revenue in Genetic Toxicology Business (2020-2025)

11.11.5 NextGen Recent Development

11.12 Cardinal Health

11.12.1 Cardinal Health Company Details

11.12.2 Cardinal Health Business Overview

11.12.3 Cardinal Health Genetic Toxicology Introduction

11.12.4 Cardinal Health Revenue in Genetic Toxicology Business (2020-2025)

11.12.5 Cardinal Health Recent Development

11.13 Toxys

11.13.1 Toxys Company Details

11.13.2 Toxys Business Overview

11.13.3 Toxys Genetic Toxicology Introduction

11.13.4 Toxys Revenue in Genetic Toxicology Business (2020-2025)

11.13.5 Toxys Recent Development

11.14 Abbott Toxicology

11.14.1 Abbott Toxicology Company Details

11.14.2 Abbott Toxicology Business Overview

11.14.3 Abbott Toxicology Genetic Toxicology Introduction

11.14.4 Abbott Toxicology Revenue in Genetic Toxicology Business (2020-2025)

11.14.5 Abbott Toxicology Recent Development

11.15 Evotec

11.15.1 Evotec Company Details

11.15.2 Evotec Business Overview

11.15.3 Evotec Genetic Toxicology Introduction

11.15.4 Evotec Revenue in Genetic Toxicology Business (2020-2025)

11.15.5 Evotec Recent Development

11.16 EPL

11.16.1 EPL Company Details

11.16.2 EPL Business Overview

11.16.3 EPL Genetic Toxicology Introduction

11.16.4 EPL Revenue in Genetic Toxicology Business (2020-2025)

11.16.5 EPL Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Accelera

Charles River

Syngene

Vivotecnia

Technics

ERBC Group

Nextgen

Cardinal Health

Toxys

Abbott Toxicology

Evotec AG

EPL Limited

Frontage Laboratories

Pharmaron

LabCorp

Aurigene Pharmaceutical Services

List of Tables

Table 1. Global Genetic Toxicology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Genotoxicity Screening Assays

Table 3. Key Players of GLP Standard Genotoxicity Assays

Table 4. Global Genetic Toxicology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Genetic Toxicology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Genetic Toxicology Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Genetic Toxicology Market Share by Region (2020-2025)

Table 8. Global Genetic Toxicology Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Genetic Toxicology Market Share by Region (2026-2031)

Table 10. Genetic Toxicology Market Trends

Table 11. Genetic Toxicology Market Drivers

Table 12. Genetic Toxicology Market Challenges

Table 13. Genetic Toxicology Market Restraints

Table 14. Global Genetic Toxicology Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Genetic Toxicology Market Share by Players (2020-2025)

Table 16. Global Top Genetic Toxicology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Toxicology as of 2024)

Table 17. Ranking of Global Top Genetic Toxicology Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Genetic Toxicology Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Genetic Toxicology, Headquarters and Area Served

Table 20. Global Key Players of Genetic Toxicology, Product and Application

Table 21. Global Key Players of Genetic Toxicology, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Genetic Toxicology Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Genetic Toxicology Revenue Market Share by Type (2020-2025)

Table 25. Global Genetic Toxicology Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Genetic Toxicology Revenue Market Share by Type (2026-2031)

Table 27. Global Genetic Toxicology Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Genetic Toxicology Revenue Market Share by Application (2020-2025)

Table 29. Global Genetic Toxicology Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Genetic Toxicology Revenue Market Share by Application (2026-2031)

Table 31. North America Genetic Toxicology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Genetic Toxicology Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Genetic Toxicology Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Genetic Toxicology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Genetic Toxicology Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Genetic Toxicology Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Genetic Toxicology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Genetic Toxicology Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Genetic Toxicology Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Genetic Toxicology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Genetic Toxicology Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Genetic Toxicology Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Genetic Toxicology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Genetic Toxicology Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Genetic Toxicology Market Size by Country (2026-2031) & (US$ Million)

Table 46. Frontage Laboratories Company Details

Table 47. Frontage Laboratories Business Overview

Table 48. Frontage Laboratories Genetic Toxicology Product

Table 49. Frontage Laboratories Revenue in Genetic Toxicology Business (2020-2025) & (US$ Million)

Table 50. Frontage Laboratories Recent Development

Table 51. Accelera Company Details

Table 52. Accelera Business Overview

Table 53. Accelera Genetic Toxicology Product

Table 54. Accelera Revenue in Genetic Toxicology Business (2020-2025) & (US$ Million)

Table 55. Accelera Recent Development

Table 56. Charles River Company Details

Table 57. Charles River Business Overview

Table 58. Charles River Genetic Toxicology Product

Table 59. Charles River Revenue in Genetic Toxicology Business (2020-2025) & (US$ Million)

Table 60. Charles River Recent Development

Table 61. Pharmaron Company Details

Table 62. Pharmaron Business Overview

Table 63. Pharmaron Genetic Toxicology Product

Table 64. Pharmaron Revenue in Genetic Toxicology Business (2020-2025) & (US$ Million)

Table 65. Pharmaron Recent Development

Table 66. Labcorp Company Details

Table 67. Labcorp Business Overview

Table 68. Labcorp Genetic Toxicology Product

Table 69. Labcorp Revenue in Genetic Toxicology Business (2020-2025) & (US$ Million)

Table 70. Labcorp Recent Development

Table 71. Syngene Company Details

Table 72. Syngene Business Overview

Table 73. Syngene Genetic Toxicology Product

Table 74. Syngene Revenue in Genetic Toxicology Business (2020-2025) & (US$ Million)

Table 75. Syngene Recent Development

Table 76. Vivotecnia Company Details

Table 77. Vivotecnia Business Overview

Table 78. Vivotecnia Genetic Toxicology Product

Table 79. Vivotecnia Revenue in Genetic Toxicology Business (2020-2025) & (US$ Million)

Table 80. Vivotecnia Recent Development

Table 81. Technics Company Details

Table 82. Technics Business Overview

Table 83. Technics Genetic Toxicology Product

Table 84. Technics Revenue in Genetic Toxicology Business (2020-2025) & (US$ Million)

Table 85. Technics Recent Development

Table 86. Aurigene Pharmaceutical Services Company Details

Table 87. Aurigene Pharmaceutical Services Business Overview

Table 88. Aurigene Pharmaceutical Services Genetic Toxicology Product

Table 89. Aurigene Pharmaceutical Services Revenue in Genetic Toxicology Business (2020-2025) & (US$ Million)

Table 90. Aurigene Pharmaceutical Services Recent Development

Table 91. ERBC Group Company Details

Table 92. ERBC Group Business Overview

Table 93. ERBC Group Genetic Toxicology Product

Table 94. ERBC Group Revenue in Genetic Toxicology Business (2020-2025) & (US$ Million)

Table 95. ERBC Group Recent Development

Table 96. NextGen Company Details

Table 97. NextGen Business Overview

Table 98. NextGen Genetic Toxicology Product

Table 99. NextGen Revenue in Genetic Toxicology Business (2020-2025) & (US$ Million)

Table 100. NextGen Recent Development

Table 101. Cardinal Health Company Details

Table 102. Cardinal Health Business Overview

Table 103. Cardinal Health Genetic Toxicology Product

Table 104. Cardinal Health Revenue in Genetic Toxicology Business (2020-2025) & (US$ Million)

Table 105. Cardinal Health Recent Development

Table 106. Toxys Company Details

Table 107. Toxys Business Overview

Table 108. Toxys Genetic Toxicology Product

Table 109. Toxys Revenue in Genetic Toxicology Business (2020-2025) & (US$ Million)

Table 110. Toxys Recent Development

Table 111. Abbott Toxicology Company Details

Table 112. Abbott Toxicology Business Overview

Table 113. Abbott Toxicology Genetic Toxicology Product

Table 114. Abbott Toxicology Revenue in Genetic Toxicology Business (2020-2025) & (US$ Million)

Table 115. Abbott Toxicology Recent Development

Table 116. Evotec Company Details

Table 117. Evotec Business Overview

Table 118. Evotec Genetic Toxicology Product

Table 119. Evotec Revenue in Genetic Toxicology Business (2020-2025) & (US$ Million)

Table 120. Evotec Recent Development

Table 121. EPL Company Details

Table 122. EPL Business Overview

Table 123. EPL Genetic Toxicology Product

Table 124. EPL Revenue in Genetic Toxicology Business (2020-2025) & (US$ Million)

Table 125. EPL Recent Development

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

Table 129. Authors List of This Report

List of Figures

Figure 1. Genetic Toxicology Picture

Figure 2. Global Genetic Toxicology Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Genetic Toxicology Market Share by Type: 2024 VS 2031

Figure 4. Genotoxicity Screening Assays Features

Figure 5. GLP Standard Genotoxicity Assays Features

Figure 6. Global Genetic Toxicology Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Genetic Toxicology Market Share by Application: 2024 VS 2031

Figure 8. Mini Ames/Ames Case Studies

Figure 9. Gene Mutation Case Studies

Figure 10. In Vitro Micronucleus Case Studies

Figure 11. Chromosome Aberration Case Studies

Figure 12. Others Case Studies

Figure 13. Genetic Toxicology Report Years Considered

Figure 14. Global Genetic Toxicology Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Genetic Toxicology Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Genetic Toxicology Market Share by Region: 2024 VS 2031

Figure 17. Global Genetic Toxicology Market Share by Players in 2024

Figure 18. Global Top Genetic Toxicology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Toxicology as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Genetic Toxicology Revenue in 2024

Figure 20. North America Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Genetic Toxicology Market Share by Country (2020-2031)

Figure 22. United States Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Genetic Toxicology Market Share by Country (2020-2031)

Figure 26. Germany Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Genetic Toxicology Market Share by Region (2020-2031)

Figure 34. China Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Genetic Toxicology Market Share by Country (2020-2031)

Figure 42. Mexico Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Genetic Toxicology Market Share by Country (2020-2031)

Figure 46. Turkey Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Genetic Toxicology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Frontage Laboratories Revenue Growth Rate in Genetic Toxicology Business (2020-2025)

Figure 50. Accelera Revenue Growth Rate in Genetic Toxicology Business (2020-2025)

Figure 51. Charles River Revenue Growth Rate in Genetic Toxicology Business (2020-2025)

Figure 52. Pharmaron Revenue Growth Rate in Genetic Toxicology Business (2020-2025)

Figure 53. Labcorp Revenue Growth Rate in Genetic Toxicology Business (2020-2025)

Figure 54. Syngene Revenue Growth Rate in Genetic Toxicology Business (2020-2025)

Figure 55. Vivotecnia Revenue Growth Rate in Genetic Toxicology Business (2020-2025)

Figure 56. Technics Revenue Growth Rate in Genetic Toxicology Business (2020-2025)

Figure 57. Aurigene Pharmaceutical Services Revenue Growth Rate in Genetic Toxicology Business (2020-2025)

Figure 58. ERBC Group Revenue Growth Rate in Genetic Toxicology Business (2020-2025)

Figure 59. NextGen Revenue Growth Rate in Genetic Toxicology Business (2020-2025)

Figure 60. Cardinal Health Revenue Growth Rate in Genetic Toxicology Business (2020-2025)

Figure 61. Toxys Revenue Growth Rate in Genetic Toxicology Business (2020-2025)

Figure 62. Abbott Toxicology Revenue Growth Rate in Genetic Toxicology Business (2020-2025)

Figure 63. Evotec Revenue Growth Rate in Genetic Toxicology Business (2020-2025)

Figure 64. EPL Revenue Growth Rate in Genetic Toxicology Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions